Viridian Therapeutics, Inc.\DE (VRDN) Acquisitions (2017)
Viridian Therapeutics, Inc.\DE (VRDN) posted quarterly Acquisitions of $1.3 million for Q1 2017.
Powered by 
Analysis
Viridian Therapeutics, Inc.\DE (VRDN) Acquisitions (2017) Analysis & Trends
Viridian Therapeutics, Inc.\DE's Acquisitions history runs 1 years deep, the most recent figure standing at $1.3 million for Q1 2017.
- In Q1 2017, Acquisitions changed N/A year-over-year to $1.3 million; the TTM figure through Dec 2017 stood at $1.3 million (changed N/A YoY), while the FY2020 annual figure was $29.4 million, changed N/A from the prior year.
- Acquisitions for Q1 2017 stood at $1.3 million.
- The five-year high for Acquisitions was $1.3 million in Q1 2017, with the low at $1.3 million in Q1 2017.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Viridian Therapeutics, Inc.\DE | 2.42 Bn | 2.42 Bn | - | - |